DRUG IDIOSYNCRASY
The justice of subjecting a whole community to the risk of idiosyncrasy during the exploitation of a new drug which merely copies or slightly modifies the action of an earlier one is at least debatable. In the absence of Government action these are matters which must continue to be referred to the conscience and scruples of the individual practitioner.